Terms: = Breast cancer AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758
244 results:
1. Analysis of 25 surgical cases of thymic neuroendocrine tumors and thymic carcinoma.
Midorikawa K; Miyahara S; Nishino N; Ueda Y; Waseda R; Shiraishi T; Sato T
J Cardiothorac Surg; 2024 Apr; 19(1):225. PubMed ID: 38627811
[TBL] [Abstract] [Full Text] [Related]
2. Development and validation of ultrasound-based radiomics model to predict germline BRCA mutations in patients with breast cancer.
Deng T; Liang J; Yan C; Ni M; Xiang H; Li C; Ou J; Lin Q; Liu L; Tang G; Luo R; An X; Gao Y; Lin X
Cancer Imaging; 2024 Feb; 24(1):31. PubMed ID: 38424620
[TBL] [Abstract] [Full Text] [Related]
3. [Identification of breast cancer subtypes based on graph convolutional network].
An Y; Liu X; Chen H; Wan G
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2024 Feb; 41(1):121-128. PubMed ID: 38403612
[TBL] [Abstract] [Full Text] [Related]
4. Triple Primary cancers: An Analysis of Genetic and Environmental Factors.
Borja NA; Silva-Smith R; Calfa C; Sussman DA; Tekin M
Cancer Prev Res (Phila); 2024 May; 17(5):209-215. PubMed ID: 38361103
[TBL] [Abstract] [Full Text] [Related]
5. Ultrasound-based radiomics nomogram for predicting axillary lymph node metastasis in early-stage breast cancer.
Zhang W; Wang S; Wang Y; Sun J; Wei H; Xue W; Dong X; Wang X
Radiol Med; 2024 Feb; 129(2):211-221. PubMed ID: 38280058
[TBL] [Abstract] [Full Text] [Related]
6. Serum miRNA Combined With Transvaginal Color Doppler Ultrasound Diagnosis Clinical Research on Cervical cancer.
Wang Y; Yang J; Wang Y
J Ultrasound Med; 2024 Apr; 43(4):791-798. PubMed ID: 38269478
[TBL] [Abstract] [Full Text] [Related]
7. Single-cell and bulk RNA sequencing analysis of B cell marker genes in TNBC TME landscape and immunotherapy.
Zhao F; Zhao C; Xu T; Lan Y; Lin H; Wu X; Li X
Front Immunol; 2023; 14():1245514. PubMed ID: 38111587
[TBL] [Abstract] [Full Text] [Related]
8. Using Radiomics to Differentiate Brain Metastases From Lung cancer Versus breast cancer, Including Predicting Epidermal Growth Factor Receptor and human Epidermal Growth Factor Receptor 2 Status.
Shi J; Chen H; Wang X; Cao R; Chen Y; Cheng Y; Pang Z; Huang C
J Comput Assist Tomogr; 2023 Nov-Dec 01; 47(6):924-933. PubMed ID: 37948368
[TBL] [Abstract] [Full Text] [Related]
9. [Real-world study of the consumption between 2017 and 2020 of anti-cancer medications that inhibit cyclin- dependent kinases 4 and 6].
Expert A; Robba L; de Lagasnerie G; Kujas P
Bull Cancer; 2023 Dec; 110(12):1272-1278. PubMed ID: 37802713
[TBL] [Abstract] [Full Text] [Related]
10. PR status is a more decisive factor in efficacy of adding pertuzumab into neoadjuvant therapy for HER2-positive and lymph node-positive breast cancer than ER status: a real-world retrospective study in China.
Liu X; Liu Z; Li C; Song X; Wang X; Li S; Yu Z
World J Surg Oncol; 2023 Sep; 21(1):296. PubMed ID: 37723497
[TBL] [Abstract] [Full Text] [Related]
11. Validating a model for predicting breast cancer and nonbreast cancer death in women aged 55 years and older.
Wolfson EA; Schonberg MA; Eliassen AH; Bertrand KA; Shvetsov YB; Rosner BA; Palmer JR; LaCroix AZ; Chlebowski RT; Nelson RA; Ngo LH
J Natl Cancer Inst; 2024 Jan; 116(1):81-96. PubMed ID: 37676833
[TBL] [Abstract] [Full Text] [Related]
12. Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials.
Zeverijn LJ; Looze EJ; Thavaneswaran S; van Berge Henegouwen JM; Simes RJ; Hoes LR; Sjoquist KM; van der Wijngaart H; Sebastian L; Geurts BS; Lee CK; de Wit GF; Espinoza D; Roepman P; Lin FP; Jansen AML; de Leng WWJ; van der Noort V; Leek LVM; de Vos FYFL; van Herpen CML; Gelderblom H; Verheul HMW; Thomas DM; Voest EE
Int J Cancer; 2023 Oct; 153(7):1413-1422. PubMed ID: 37424386
[TBL] [Abstract] [Full Text] [Related]
13. A body shape index (ABSI) is associated inversely with post-menopausal progesterone-receptor-negative breast cancer risk in a large European cohort.
Christakoudi S; Tsilidis KK; Dossus L; Rinaldi S; Weiderpass E; Antoniussen CS; Dahm CC; Tjønneland A; Mellemkjær L; Katzke V; Kaaks R; Schulze MB; Masala G; Grioni S; Panico S; Tumino R; Sacerdote C; May AM; Monninkhof EM; Quirós JR; Bonet C; Sánchez MJ; Amiano P; Chirlaque MD; Guevara M; Rosendahl AH; Stocks T; Perez-Cornago A; Tin Tin S; Heath AK; Aglago EK; Peruchet-Noray L; Freisling H; Riboli E
BMC Cancer; 2023 Jun; 23(1):562. PubMed ID: 37337133
[TBL] [Abstract] [Full Text] [Related]
14. Gene Expression Profiling of Fibroepithelial Lesions of the breast.
Li X; Vail E; Maluf H; Chaum M; Leong M; Lownik J; Che M; Giuliano A; Cao D; Dadmanesh F
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240386
[TBL] [Abstract] [Full Text] [Related]
15. Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health records from a regional UK-based hospital.
Seesaghur A; Egger P; Warden J; Abbasi A; Levick B; Riaz M; McMahon P; Thompson M; Cheeseman S
BMJ Open; 2023 May; 13(5):e069214. PubMed ID: 37156580
[TBL] [Abstract] [Full Text] [Related]
16. cancer survival in the northwestern of São Paulo State, Brazil: A population-based study.
Mafra A; Bardot A; Charvat H; Weiderpass E; Soerjomataram I; Fregnani JHTG
Cancer Epidemiol; 2023 Apr; 83():102339. PubMed ID: 36863216
[TBL] [Abstract] [Full Text] [Related]
17. Contrasts Between Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MR in Diagnosing Malignancies of breast Nonmass Enhancement Lesions Based on Morphologic Assessment.
Li Y; Chen J; Yang Z; Fan C; Qin Y; Tang C; Yin T; Ai T; Xia L
J Magn Reson Imaging; 2023 Sep; 58(3):963-974. PubMed ID: 36738118
[TBL] [Abstract] [Full Text] [Related]
18. Identification of a Novel Gene Signature with DDR and EMT Difunctionalities for Predicting Prognosis, Immune Activity, and Drug Response in breast cancer.
Zhang P; Li Q; Zhang Y; Wang Q; Yan J; Shen A; Hu B
Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36673982
[TBL] [Abstract] [Full Text] [Related]
19. Polymorphisms in
Firfirey F; Shamley D; September AV
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672750
[TBL] [Abstract] [Full Text] [Related]
20. Detection and classification of breast lesions with You Only Look Once version 5.
Meng M; Zhang M; Shen D; He G; Guo Y
Future Oncol; 2022 Dec; 18(39):4361-4370. PubMed ID: 36519579
[TBL] [Abstract] [Full Text] [Related]
[Next]
